Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MELAcare Study: a Randomized Controlled Trial of a New Method for Surveillance of Melanoma Patients

NCT05253872 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.

NCT NCT05253872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05253872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MELAcare Study: a Randomized Controlled Trial of a New Method for Surveillance of Melanoma Patients
Lead sponsor
Herlev and Gentofte Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 9, 2022
Completion date
March 31, 2028
Enrollment
378 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma